RespireRx Pharmaceuticals
- Pharmaceutical Preparations
- Glen Rock, New Jersey
Compensation history
Top executives at RespireRx Pharmaceuticals received an average of $462K per person in annual compensation from 2006 to 2009.
By year
- 2009
MV$465KMark A. VarneyPresident and Chief Executive OfficerRS$399KRoger G. StollExecutive ChairmanPT$328KPierre V. TrânChief Medical Officer and Vice President of Clinical DevelopmentMM$264KMaria S. MessingerVice President, Chief Financial Officer and Corporate SecretaryJC$261KJames H. ColemanSenior Vice President, Business Development- 2008
MV$677KMark A. VarneyPresident and Chief Executive OfficerRS$457KRoger G. StollExecutive ChairmanPT$413KPierre V. TrânChief Medical Officer and Vice President of Clinical DevelopmentJC$308KJames H. ColemanSenior Vice President, Business DevelopmentMM$302KMaria S. MessingerVice President, Chief Financial Officer and Corporate Secretary- 2007
PT$552KPierre V. TrânChief Medical Officer and Vice President of Clinical DevelopmentMV$466KMark A. VarneyPresident and Chief Executive OfficerRS$387KRoger G. StollExecutive ChairmanJC$249KJames H. ColemanSenior Vice President, Business DevelopmentMM$225KMaria S. MessingerVice President, Chief Financial Officer and Corporate Secretary
Executives
We found seven executives who work or worked at RespireRx Pharmaceuticals.
Roger Stoll
RespireRx Pharmaceuticals
Chairman
Mark Varney
RespireRx Pharmaceuticals
Chief Executive Officer
Pierre Trân
RespireRx Pharmaceuticals
Chief Medical Officer
Maria Messinger
RespireRx Pharmaceuticals
Chief Financial Officer
James Coleman
RespireRx Pharmaceuticals
Senior Vice President, Business Development
Harry Mansbach
RespireRx Pharmaceuticals
Chief Medical Officer
Gary Rogers
RespireRx Pharmaceuticals
Senior Vice President, Pharmaceutical Research
News
About RespireRx Pharmaceuticals
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 126 Valley Road, Suite C, Glen Rock, New Jersey 07452
- (201) 444-4947
- December 31
- Former names
- CORTEX PHARMACEUTICALS INC/DE/